vs
Encompass Health Corp（EHC）とRB GLOBAL INC.（RBA）の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい（$1.5B vs $1.2B、RB GLOBAL INC.の約1.3倍）。Encompass Health Corpの純利益率が高く（9.5% vs 9.1%、差は0.3%）。Encompass Health Corpの前年同期比売上増加率が高い（9.9% vs 5.4%）。RB GLOBAL INC.の直近四半期フリーキャッシュフローが多い（$186.5M vs $116.7M）。過去8四半期でEncompass Health Corpの売上複合成長率が高い（8.3% vs 6.3%）
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
リッチーブラザーズオークショニア（証券コードRBA）はカナダに登記されている上場企業で、本社は米国イリノイ州ウェストチェスターに所在し、普通株式はトロント証券取引所とニューヨーク証券取引所の両方で取引されています。
EHC vs RBA — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $1.5B | $1.2B |
| 純利益 | $146.1M | $109.7M |
| 粗利率 | — | — |
| 営業利益率 | 16.7% | 14.7% |
| 純利益率 | 9.5% | 9.1% |
| 売上前年比 | 9.9% | 5.4% |
| 純利益前年比 | 20.8% | -7.4% |
| EPS（希薄化後） | $1.43 | $0.53 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.5B | $1.1B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.5B | $1.1B | ||
| Q4 24 | $1.4B | $1.1B | ||
| Q3 24 | $1.4B | $981.8M | ||
| Q2 24 | $1.3B | $1.1B | ||
| Q1 24 | $1.3B | $1.1B |
| Q4 25 | $146.1M | $109.7M | ||
| Q3 25 | $126.5M | $95.5M | ||
| Q2 25 | $142.1M | $109.8M | ||
| Q1 25 | $151.5M | $113.4M | ||
| Q4 24 | $120.9M | $118.5M | ||
| Q3 24 | $108.2M | $76.1M | ||
| Q2 24 | $114.1M | $111.1M | ||
| Q1 24 | $112.5M | $107.4M |
| Q4 25 | 16.7% | 14.7% | ||
| Q3 25 | 14.9% | 14.5% | ||
| Q2 25 | 16.2% | 15.9% | ||
| Q1 25 | 16.4% | 17.1% | ||
| Q4 24 | 14.3% | 18.1% | ||
| Q3 24 | 13.6% | 15.6% | ||
| Q2 24 | 14.3% | 18.4% | ||
| Q1 24 | 13.6% | 18.7% |
| Q4 25 | 9.5% | 9.1% | ||
| Q3 25 | 8.6% | 8.7% | ||
| Q2 25 | 9.7% | 9.3% | ||
| Q1 25 | 10.4% | 10.2% | ||
| Q4 24 | 8.6% | 10.4% | ||
| Q3 24 | 8.0% | 7.8% | ||
| Q2 24 | 8.8% | 10.1% | ||
| Q1 24 | 8.5% | 10.1% |
| Q4 25 | $1.43 | $0.53 | ||
| Q3 25 | $1.24 | $0.43 | ||
| Q2 25 | $1.39 | $0.53 | ||
| Q1 25 | $1.48 | $0.55 | ||
| Q4 24 | $1.18 | $0.58 | ||
| Q3 24 | $1.06 | $0.36 | ||
| Q2 24 | $1.12 | $0.54 | ||
| Q1 24 | $1.10 | $0.53 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $72.2M | $531.5M |
| 総負債低いほど良い | $2.4B | $2.3B |
| 株主資本純資産 | $2.4B | $5.6B |
| 総資産 | $7.1B | $12.1B |
| 負債/資本比率低いほどレバレッジが低い | 1.00× | 0.42× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $72.2M | $531.5M | ||
| Q3 25 | $48.7M | $674.7M | ||
| Q2 25 | $99.1M | $710.2M | ||
| Q1 25 | $95.8M | $578.1M | ||
| Q4 24 | $85.4M | $533.9M | ||
| Q3 24 | $147.8M | $650.7M | ||
| Q2 24 | $154.4M | $599.5M | ||
| Q1 24 | $134.4M | $462.8M |
| Q4 25 | $2.4B | $2.3B | ||
| Q3 25 | $2.4B | $2.6B | ||
| Q2 25 | $2.3B | $2.6B | ||
| Q1 25 | $2.3B | $2.6B | ||
| Q4 24 | $2.4B | $2.6B | ||
| Q3 24 | $2.3B | $2.7B | ||
| Q2 24 | $2.7B | $2.8B | ||
| Q1 24 | $2.7B | $2.9B |
| Q4 25 | $2.4B | $5.6B | ||
| Q3 25 | $2.4B | $5.5B | ||
| Q2 25 | $2.3B | $5.5B | ||
| Q1 25 | $2.2B | $5.3B | ||
| Q4 24 | $2.1B | $5.2B | ||
| Q3 24 | $2.0B | $5.2B | ||
| Q2 24 | $1.8B | $5.2B | ||
| Q1 24 | $1.7B | $5.1B |
| Q4 25 | $7.1B | $12.1B | ||
| Q3 25 | $6.9B | $12.2B | ||
| Q2 25 | $6.8B | $12.2B | ||
| Q1 25 | $6.6B | $11.9B | ||
| Q4 24 | $6.5B | $11.8B | ||
| Q3 24 | $6.5B | $11.9B | ||
| Q2 24 | $6.4B | $12.1B | ||
| Q1 24 | $6.2B | $12.0B |
| Q4 25 | 1.00× | 0.42× | ||
| Q3 25 | 1.01× | 0.47× | ||
| Q2 25 | 1.02× | 0.47× | ||
| Q1 25 | 1.08× | 0.50× | ||
| Q4 24 | 1.14× | 0.50× | ||
| Q3 24 | 1.20× | 0.52× | ||
| Q2 24 | 1.46× | 0.55× | ||
| Q1 24 | 1.54× | 0.58× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $346.0M | $255.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $116.7M | $186.5M |
| FCFマージンFCF / 売上 | 7.6% | 15.5% |
| 設備投資強度設備投資 / 売上 | 14.8% | 5.7% |
| キャッシュ転換率営業CF / 純利益 | 2.37× | 2.33× |
| 直近12ヶ月FCF直近4四半期 | $439.2M | $719.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $346.0M | $255.2M | ||
| Q3 25 | $270.8M | $239.7M | ||
| Q2 25 | $270.2M | $326.5M | ||
| Q1 25 | $288.6M | $156.8M | ||
| Q4 24 | $278.8M | $184.5M | ||
| Q3 24 | $267.8M | $285.4M | ||
| Q2 24 | $217.4M | $337.3M | ||
| Q1 24 | $238.8M | $124.8M |
| Q4 25 | $116.7M | $186.5M | ||
| Q3 25 | $83.7M | $188.5M | ||
| Q2 25 | $113.3M | $241.7M | ||
| Q1 25 | $125.5M | $102.5M | ||
| Q4 24 | $80.1M | $127.9M | ||
| Q3 24 | $120.3M | $248.5M | ||
| Q2 24 | $60.5M | $308.6M | ||
| Q1 24 | $99.4M | $79.6M |
| Q4 25 | 7.6% | 15.5% | ||
| Q3 25 | 5.7% | 17.3% | ||
| Q2 25 | 7.8% | 20.4% | ||
| Q1 25 | 8.6% | 9.2% | ||
| Q4 24 | 5.7% | 11.2% | ||
| Q3 24 | 8.9% | 25.3% | ||
| Q2 24 | 4.6% | 28.2% | ||
| Q1 24 | 7.6% | 7.5% |
| Q4 25 | 14.8% | 5.7% | ||
| Q3 25 | 12.7% | 4.7% | ||
| Q2 25 | 10.8% | 7.2% | ||
| Q1 25 | 11.2% | 4.9% | ||
| Q4 24 | 14.1% | 5.0% | ||
| Q3 24 | 10.9% | 3.8% | ||
| Q2 24 | 12.1% | 2.6% | ||
| Q1 24 | 10.6% | 4.2% |
| Q4 25 | 2.37× | 2.33× | ||
| Q3 25 | 2.14× | 2.51× | ||
| Q2 25 | 1.90× | 2.97× | ||
| Q1 25 | 1.90× | 1.38× | ||
| Q4 24 | 2.31× | 1.56× | ||
| Q3 24 | 2.48× | 3.75× | ||
| Q2 24 | 1.91× | 3.04× | ||
| Q1 24 | 2.12× | 1.16× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
RBA
| Buyer Revenue | $577.2M | 48% |
| Seller Revenue | $255.2M | 21% |
| CA | $199.0M | 17% |
| Other | $124.7M | 10% |
| AU | $47.3M | 4% |
